4-[(3R)-3-(2-chloro-3-methoxy-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine
C18H23ClN4O4S — CID 175083617
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-[(3R)-3-(2-chloro-3-methoxy-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine
4-[(3R)-3-(2-chloro-3-methoxy-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine (PubChem CID 175083617) has the molecular formula C18H23ClN4O4S and a molecular weight of 426.93 g/mol. Its IUPAC name is 4-[(3R)-3-(2-chloro-3-methoxy-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine.
Molecular Properties
| Compound Name | 4-[(3R)-3-(2-chloro-3-methoxy-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine |
|---|---|
| PubChem CID | 175083617 |
| Molecular Formula | C18H23ClN4O4S |
| Molecular Weight | 426.93 g/mol |
| Exact Mass | 426.11 |
| IUPAC Name | 4-[(3R)-3-(2-chloro-3-methoxy-4-methylsulfonylphenyl)-1,4-oxazepan-4-yl]-6-methylpyrimidin-2-amine |
| SMILES | COc1c(S(C)(=O)=O)ccc([C@@H]2COCCCN2c2cc(C)nc(N)n2)c1Cl |
| InChI | InChI=1S/C18H23ClN4O4S/c1-11-9-15(22-18(20)21-11)23-7-4-8-27-10-13(23)12-5-6-14(28(3,24)25)17(26-2)16(12)19/h5-6,9,13H,4,7-8,10H2,1-3H3,(H2,20,21,22)/t13-/m0/s1 |
| InChIKey | YAGHYLBGSCAXCQ-ZDUSSCGKSA-N |
| XLogP | 2.40 |
| TPSA | 107.64 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 426.93 |
| LogP ≤ 5 | 2.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175083617 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.